Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis

BACKGROUND: To identify the pattern of failure and oncological safety of hippocampus (HC)-sparing IMRT (HSRT) in newly diagnosed glioblastoma (GBM) patients. MATERIALS AND METHODS: Eighty-two GBM patients treated with temozolomide-based chemoradiation using HSRT between 2014 and 2018 were retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wee, Chan Woo, Kim, Kyung Su, Kim, Chae-Yong, Han, Jung Ho, Kim, Yu Jung, Kim, In Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204282/
https://www.ncbi.nlm.nih.gov/pubmed/32375876
http://dx.doi.org/10.1186/s13014-020-01552-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204282/
https://www.ncbi.nlm.nih.gov/pubmed/32375876
http://dx.doi.org/10.1186/s13014-020-01552-0

Ejemplares similares